Vanda Pharmaceuticals Inc. provided revenue guidance for the year 2022. For the year 2022, the company expects total revenues in the range of $240 million to $280 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.48 USD | -1.79% | +8.73% | +29.86% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.86% | 319M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Vanda Pharmaceuticals Inc. Provides Revenue Guidance for the Year 2022